• Home
  • NEW DAY MEDICINE
  • 3 (35) 2021
  • 17 -3 (35) 2021 — Akhmedov F.K., Negmatullaeva M.N. -GENETIC FACTORS AND THEIR IMPORTANCE IN DETERMINING THE PROGNOSIS OF PREECLAMPSIA

17 -3 (35) 2021 — Akhmedov F.K., Negmatullaeva M.N. -GENETIC FACTORS AND THEIR IMPORTANCE IN DETERMINING THE PROGNOSIS OF PREECLAMPSIA

GENETIC FACTORS AND THEIR IMPORTANCE IN DETERMINING THE PROGNOSIS OF PREECLAMPSIA

Akhmedov F.K., Bukhara Medical Institute named after Abu Ali ibn Sino. Bukhara, Uzbekistan

 Negmatullaeva M.N. Bukhara Medical Institute named after Abu Ali ibn Sino. Bukhara, Uzbekistan

Resume

Since hypertensive disorders during pregnancy are associated with high rates of maternal and perinatal mortality, it is important that obstetricians identify severe cases with a difficult prognosis in a timely manner. The levels of interleukin-1b, interleukin-10 and TNF-α were determined in I , II  and III trimesters of pregnancy to determine the risk of preeclampsia. Although the final pathogenesis of this pathology has yet to be clarified, on the basis of this it will be possible to develop an adequate therapy algorithm to save the life of the mother and child.

Key words: pregnancy, fetus, genes, preeclampsia

First page

89

Last page

94

For citation: Akhmedov F.K., Negmatullaeva M.N. GENETIC FACTORS AND THEIR IMPORTANCE IN DETERMINING THE PROGNOSIS OF PREECLAMPSIA //New Day in Medicine 3(35)2021 89-94 https://cutt.ly/ZQDT7t0

List of References:

  1. Ахмедов Ф.К., Курбонова З.Ш. Мочевая кислота – маркер развития преэклампсия //Новости дерматологии и репродуктивного здоровья. – 2017. – №3-4(II). – С. 27-29.
  2. Ахмедов Ф.К., Курбанова З.Ш. Преэклампсияни ташхислашда қон ва сийдикда сийдик кислотаси концентрациясининг роли //Тиббиётда янги кун. – 2017.- №1. – Б. 119-122.
  3. Akhmedov F.K., Negmatullaeva M.N., Features of the state of central hemodynamics and hemostasis in pregnant women with preeclampsia of varying severity//New Day in Medicine 1(29)2020 144-147 https://newdaymedicine.com/?p=5599
  4. Туксанова Д.И., Д.К.Нажмутдинова., Д.Я.Зарипова. Влияние давности течения преэклампсии на исходы беременности и родов //Новости дерматологии и репродуктивного здоровья. – 2015. – №3. – С. 119-120.
  5. Tuksanova D.I., Avakov V.E., Nazhmutdinova D.K. Features of the state of the parameters of homeostasis and cardio hemodynamics in women with physiological pregnancy//New Day in Medicine 1(25)2019 159-162 https://cutt.ly/LbFgwrT
  6. Туксанова Д.И. Особенности изменений показателей системного и органного кровотока у женщин при тяжёлой преэклампсией // Международный Казахско-Турецкий Университет “Современная медицина традиции и инновации”. – Казакстан 2018. – С. 151-155.
  7. Туксанова Д.И., Шарипова М. Анализ комплексного обследования женщин с преэклампсией и сочетанной анемией // Проблемы медицины и биологии. – Кемерово 2018. – №4. – С. 195-198.
  8. Маркеры преэклампсии в I и III триместрах беременности / Т. Ю. Иванец [и др.] // Проблемы репродукции. – 2012. – Т. 18, № 3. – С. 83–87.
  9. Патогенетические аспекты преэклампсии // Д. А. Борис [и др.] // Акушерство и гинекология. – 2015. – № 12. – С. 11-15.
  10. Angiogenic factors for the prediction of preeclampsia in high-risk women / T.A. Moore Simas [et al.] // Am. J. Obstet. Gynecol.– 2007.–Vol. 197, N 3.– P. 241-248.
  11. Lee Y.H., Kim J.H., Song G.G. Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to preeclampsia. //Eur J Obstet Gynecol Reprod Biol. 2014 Nov; 182:202-7. doi: 10.1016/j.ejogrb.2014.09.030. Epub 2014 Sep 27.PMID: 25305663 Review.
  12. Zhou L., Cheng L., He Y., Gu Y., Wang Y. Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNF- alpha with preeclampsia in Chinese women. C. Inflamm Res. 2016 Sep;65(9):717-24. doi: 10.1007/s00011-016-0953-y. Epub 2016 May 27.PMID: 27233255.
  13. Xie C., Yao M.Z., Liu J.B., Xing L.K. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2018 Dec; 56(3):550-9. doi: 10.1016/j.cyto.2011.09.021. Epub 2011 Oct 21.PMID: 22019000
  14. Vural P., Değirmencioğlu S., Saral N.Y., Akgül C. Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome. //Eur J Obstet Gynecol Reprod Biol. 2018 May;150(1):61-5. doi: 10.1016/j.ejogrb.2010.02.010. Epub 2010 Mar 1.PMID: 20189706.
  15. Vural P., Degirmencioglu S., Saral N.Y., Demirkan A., Akgul C., Yildirim G, Issever H., Eroglu H. Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. //J Obstet Gynaecol Res. 2019 Feb;36(1):64-71. doi: 10.1111/j.1447-0756.2009.01111.x.PMID: 20178529.
  16. Stonek F., Hafner E., Metzenbauer M., Katharina S., Stümpflen I., Schneeberger C., Zeisler H., Husslein P., Philipp K.J. Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. Reprod Immunol. 2018 Jan;77(1):85-90. doi: 10.1016/j.jri.2007.04.003. Epub 2007 Jun 4.PMID: 17544514.
  17. Nath M.C., Cubro H., McCormick D.J., Milic N.M., Garovic V.D. Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis: Systematic Review and Meta-Analysis. Hypertension.2020 Dec; 76(6):1817-1827. doi: 10.1161/ HYPERTENSIONAHA. 120.15870. Epub 2020 Oct 26.PMID: 33100048
  18. Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNFalpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants / C. Royle [et al.] // Cytokine. – 2019. – Vol. 47, № 1. – Р. 56-60.
  19. Lee, Y. H. Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to pre-eclampsia / Y. H. Lee, J. H. Kim, G. G. Song // Eur J Obstet Gynecol Reprod Biol. – 2014. – Vol. 182. – Р. 202-207.
  20. Polymorphisms in interleukin-6 and interleukin-10 may be associated with risk of preeclampsia / D. M. Fan [et al.] // Genet Mol Res. – 2017. – Vol. 16, № 1. – gmr 16018588.

file

download